Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma.

The present study was designed in order to evaluate the response rate and the toxicity of continuous infusion of Interleukin 2 (IL2) in patients over 65 with metastatic renal cell carcinoma. Twenty-five patients, median age 69 (range 65-77), without any prior systemic anticancer therapy received a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Négrier, S., Mercatello, A., Bret, M., Thiesse, P., Blay, J. Y., Coronel, B., Merrouche, Y., Oskam, R., Franks, C. R., Clavel, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977403/
https://www.ncbi.nlm.nih.gov/pubmed/1586600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977403/
https://www.ncbi.nlm.nih.gov/pubmed/1586600

Ejemplares similares